Literature DB >> 1898878

[The psychological aspects of diabetics with the secondary failure of sulfonylurea therapy].

K P Ratzmann1.   

Abstract

Forty diabetics (19 men, 21 women; mean age 54 [41-66] years) with secondary failure of sulfonylurea treatment, were assessed by questionnaire (psychological-neurological state; scale of well-being; attitude towards achievement, and psychological aspects of performance), both before and four months after being put on insulin treatment, as to the way in which they experienced and dealt with the illness. Before the onset of insulin treatment, a general decrease in performance was the predominant symptom (29 patients), while only about half of the patients declared diabetes-specific symptoms. The necessity of insulin administration was experienced by 34 patients as a severe crisis in their chronic illness. Anxiety over failure in the act of injection (30 patients), as well as fear of the consequences regarding their job (25 patients) and of restriction in the personal sphere (31 patients) were the chief reasons for their dislike of insulin treatment. Four months after starting insulin treatment these anxieties had largely disappeared. The only remaining fear was that the necessity of insulin treatment meant that a serious stage of the disease had been reached (before insulin, 36; after insulin 18 patients). It is concluded that such patients should, as part of group therapy, become active participants in the instructions given to diabetics so that other patients can profit from their experience.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898878     DOI: 10.1055/s-2008-1063586

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Quality-of-life evaluation in diabetes.

Authors:  C Eiser; J E Tooke
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

2.  Quality of life following a change in therapy for diabetes mellitus.

Authors:  M Pibernik-Okanović; S Szabo; Z Metelko
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 3.  Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient care.

Authors:  Frank Lavernia
Journal:  Medscape J Med       Date:  2008-09-17

4.  Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study.

Authors:  Hitoshi Ishii; Tetsuji Niiya; Yasuhiro Ono; Naoyuki Inaba; Hideaki Jinnouchi; Hirotaka Watada
Journal:  Diabetol Metab Syndr       Date:  2017-01-07       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.